Wikidata

(Q44592639)

English

Transient benefit only from increasing the imatinib dose in CML patients who do not achieve complete cytogenetic remissions on conventional doses

scientific article published on October 1, 2003

In more languages

Statements

title
Transient benefit only from increasing the imatinib dose in CML patients who do not achieve complete cytogenetic remissions on conventional doses (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
14504074
retrieved
4 December 2017
page(s)
2702-3; author reply 2703-4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
14504074
retrieved
4 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44592639&oldid=2101994651"